Physicians See Benefits From PDMP Integration With Health Records

Prescription drug monitoring programs can be an important tool in limiting opioid addiction, researchers said, but they are most frequently used when they are integrated with a larger electronic health record system.

Site Name: 
InsideHealthPolicy.com
Author: 






U.N.-Backed Group Announces First Deal To Make Generic Cancer Drugs

The United Nations-backed Medicines Patent Pool is expanding its voluntary licensing program to oncology drugs.

Site Name: 
InsideHealthPolicy.com
IDP Issue: 
Inside Drug Pricing - 10/24/2022
IDP Volume: 
Vol. 5, No. 42
Author: 

FDA Suspends Compounding MOU, Plans To Pursue Rulemaking

FDA is delaying indefinitely enforcement of its 5% sales cap on human drug compounders who distribute their products out of state and is suspending its final memorandum of understanding that sought to give state pharmacy boards a key monitoring role over pharmacy compounding.

Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 10/28/2022
FDA Volume: 
Vol. 28, No. 43
Author: 


GOP Lawmakers Urge FDA To Focus On Non-Opioid Pain Therapies

In a letter sent to FDA chief Robert Califf Wednesday (Oct. 19), four GOP senators demand FDA ramp up focus on development of non-opioid pain medication, the current supply of which is “alarmingly insufficient,” and carry out its mandates under major opioid legislation that was enacted in 2018.

Site Name: 
InsideHealthPolicy.com
FDA Issue: 
FDA Week - 10/28/2022
FDA Volume: 
Vol. 28, No. 43
Author: 




Pages

Log in to access this content.

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.